Reflections on the thrombolic venous disease;Reflexiones sobre la enfermedad tromboembólica venosa

Anales de Medicina Interna

Volumn 20, Issue 9, 2003, Pages 447-450

  Botella, F Gabriel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGE DISTRIBUTION; CLINICAL FEATURE; DEMOGRAPHY; DOPPLER ECHOGRAPHY; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG EMBOLISM; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; THROMBOEMBOLISM; VEIN THROMBOSIS;

HUMANS; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0142073786     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (29)

1. Ascari E, Siragusa S, Piovela F. The epidemiology of deep vein thrombosis and pulmonary embolism. Haematologica 1995; 80 (Supl. 2): 36-41.
2. Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O'Fallon WM. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
3. Montes J, Rey G, Mediero A. Variaciones estacionales en la morbimortalidad por tromboembolismo pulmonar en Galicia. An Med Interna (Madrid) 2003; 20: 457-460.
4. Rosendo A, Fernández D, Lucio R, Latorre J. Epidemiología. In: Güell J, Rosendo A, editors. Enfermedad Tromboembólica venosa (E.T.E.V). Síndrome Postrombótico. Barcelona: EDIKA MED; 1995 p. 1-5.
5. Bonal de Falgas J. Comité de profilaxis de la enfermedad tromboembólica. Estudio económico de la E.T.E.V. Incídencia de TVP y costos de los tratamientos. Boletín del Comité de Profilaxis de la Enfermedad Tromboembólica 1992; 4: 3-25.
6. Gabriel F, Labiós M, Brasó JV. Trombosis venosa profunda: presente y futuro. Med Clin (Barc) 2000; 114: 584-596.
7. Echegaray M, Alonso J, Aránzazu M, Abínzano M, Gonzalez C, Solano M. Tromboembolismo pulmonar: evolución a largo plazo y epidemilogía clínica. An Med Interna (Madrid) 2003; 20: 451-456.
8. Schmid-Schönbein GW, Takase S, Bergan JJ. New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 2001; 52: S27-S28.
9. Berqvist D, Burmark VS, Frisell J, Hallbook T, Lindblad B, Risberg B. Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 1986; 73 (3): 204-208.
10. Geerts WH, Heit JA, Clagget GP, Pineo GF, Colwell CW, Anderson FA Jr. Prevention of venous thromboembolism. Chest 2001; 119 (Supl. 1): 132S-175S.
11. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997; 34: 171-187.
12. Schafer AI. Venous thrombosis as a chronic disease. N Engl J Med 1999; 340: 955-956.
13. Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795-1798.
14. Ruiz-Giménez N, Friera A, Sanchez P, Caballero P, Rodriguez-Salvanes F, Suarez C. Trombosis venosa profunda en miembros inferiores en un servicio de urgencias. Utilidad de un modelo clínico de estratificación de riesgo. Med Clin (Barc) 2002; 118: 529-533.
15. Larsen TB, Stoffersen E, Christensen CS, Laursen B. Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med 2002; 252: 36-40.
16. Fraser JD, Anderson DR. Deep venous thrombosis: Recent advances and optimal investigation with US. Radiology 1999; 211: 9-24.
17. Fraser DG, Moody AR, Morgan PS, Martel AL, Davidson I. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136: 89-98.
18. Larsson EM, Sunden P, Olsson CG, Debatin J, Duerinckx AJ, Baum R, et al. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage. AJR Am J Roentgenol 2003; 180: 227-232.
19. Wells PS, Ginsberg JS, Anderson DR, Kearon C, Gent M, Turpie AG, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129: 997-1005.
20. Garg K, Sieler H, Welsh CH, Johnston RJ, Russ PD. Clinical validity of helical CT being interpreted as negative for pulmonary embolism: implications for patient treatment. AJR Am J Roentgenol 1999; 172: 1627-1631.
21. Claggett GP, Anderson FA, Geerts W, Heit JA, Knudson M, Lieberman JR. Prevention of venous thromboembolism. Chest 1998; 114: 531S-560S.
22. Egger B, Schmid SW, Naef M, Wildi S, Buchler MW. Efficacy and safety of weight-adapted nadroparin calcium vs heparin sodium in prevention of clinically evident thromboembolic complication in 1190 general surgical patients. Diag Surg 2000; 17: 602-609.
23. Hettiarachchi RJ, Lok J, Prins MH, Buller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer 1998; 83: 180-185.
24. Monreal M. Fondaparinux en la profilaxis de la trombosis en cirugía ortopédica. ¿Una revolución?. Med Clin (Barc) 2003; 120: 775-776.
25. Prins MH, Hutten BA, Koopman MMW, Buller HR. Long-term treatment of venous thromboembolic disease. Thromb Haemost 1999; 82: 892-898.
26. Lopez-Beret P, Orgaz A, Fontcuberta J, Doblas M, Martinez A, Lozano A, et al. Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous trombosis. J Vasc Surg 2001; 33: 77-90.
27. Agnelli G, Prandoni P, Santamaría MG, Bagatella P, Iorio A, Basan M, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous trombosis. N Engl J Med 2001; 345: 165-169.
28. Hyers T, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119: 17S-93S.
29. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-681.